Clinical Trial Update: Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immunogenicity of a trivalent influenza vaccine in patients with chronic kidney disease undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Influenza vaccine, trivalent, inactivated (inactivated influenza vaccine, trivalent)

Snippet

Sponsor: Korea University Guro Hospital | Conditions: Influenza, End Stage Renal Failure | Phase 4 | Status: COMPLETED